59. “Easier than Impossible.” Guest, Rachel Sachs.
Published June 12, 2016
36 min
    Add to queue
    Copy URL
    Show notes
    A broad-ranging discussion about innovation in drug and related markets. How do patent law, FDA regulation, and CMS rate-setting intersect? Is more coordination warranted or possible? Can government insurance systems be leveraged to spur innovation in drugs we need but which may not be particularly profitable?
        0:00:00 / 0:00:00